# Data Processing Record Template (GDPR Article 30)
## For Clinical Trial EDC Systems

*Required for organizations with 250+ employees or high-risk processing*

---

## CONTROLLER INFORMATION

**Organization Name:** [Your Organization Name]
**Registration Number:** [Company/Org Registration]
**Address:** [Full Address]
**Contact Person:** [DPO or Privacy Officer]
**Email:** [Contact Email]
**Last Updated:** [Date]

---

## PROCESSING ACTIVITY 1: CLINICAL TRIAL DATA COLLECTION

### 1.1 Basic Information
- **Activity Name:** Clinical Trial Data Collection and Management
- **Description:** Collection, storage, and analysis of health data from clinical trial participants using electronic data capture (EDC) system
- **Controller:** [Your Organization Name]
- **Joint Controllers:** [If applicable - list co-investigators]
- **Data Protection Officer:** [DPO Name and Contact]

### 1.2 Legal Basis

#### For Regular Personal Data (Article 6)
- **Primary Basis:** Article 6(1)(f) - Legitimate interests
- **Legitimate Interest:** Scientific research for public health benefit
- **Balancing Test:** Conducted on [Date] - documented separately
- **Secondary Basis:** Article 6(1)(a) - Consent (where applicable)

#### For Special Category Data (Article 9)
- **Primary Basis:** Article 9(2)(j) - Scientific research with safeguards
- **Secondary Basis:** Article 9(2)(a) - Explicit consent
- **Safeguards:** Pseudonymization, access controls, ethical approval

### 1.3 Data Categories

#### Personal Data Collected
| Category | Examples | Source |
|----------|----------|---------|
| Demographics | Age, gender, education | Direct from participant |
| Health Data | Medical history, test results | Direct + healthcare providers |
| Study Data | Assessment scores, visit dates | Generated during study |
| Contact Info | Name, address, phone | Direct from participant |

#### Special Categories (Article 9)
- ✅ Health data (primary purpose)
- ❌ Racial/ethnic origin (not collected)
- ❌ Religious beliefs (not collected)
- ❌ Trade union membership (not collected)
- ❌ Genetic data (specify if applicable)
- ❌ Biometric data (specify if applicable)
- ❌ Sexual orientation (not collected)

### 1.4 Data Subjects
- **Primary:** Clinical trial participants (adults 18-85 years)
- **Secondary:** Legal representatives (for participants lacking capacity)
- **Estimated Numbers:** [X] participants per year
- **Geographic Scope:** [Countries/regions]

### 1.5 Recipients

#### Internal Recipients
- Research investigators and authorized staff
- Data management team
- Quality assurance personnel
- IT support (data processors)

#### External Recipients
- **Regulatory Authorities:** FDA, EMA, [National authorities]
- **Ethics Committees:** [IRB/Ethics board names]
- **Study Sponsors:** [Sponsor organization if applicable]
- **Service Providers:** [IT vendors, CROs - list with contracts]

### 1.6 International Transfers

| Recipient Location | Safeguard | Date Implemented |
|-------------------|-----------|------------------|
| European Union | Adequacy decision | N/A |
| United States | Standard Contractual Clauses | [Date] |
| [Other countries] | [Specific safeguards] | [Date] |

**Transfer Documentation:** Available upon request

### 1.7 Retention Periods

| Data Type | Retention Period | Trigger | Disposal Method |
|-----------|-----------------|---------|-----------------|
| Clinical data | 25 years | Study completion | Secure deletion |
| Consent records | 25 years | Study completion | Secure deletion |
| Contact information | 3 years | Study completion | Secure deletion |
| Audit logs | 7 years | Creation date | Secure deletion |

**Retention Review:** Annual review process established

### 1.8 Security Measures

#### Technical Measures
- **Encryption:** AES-256 for data at rest, TLS 1.3 for transmission
- **Access Control:** Role-based access with MFA
- **Audit Logging:** Comprehensive activity tracking
- **Backup:** Encrypted daily backups with 3-2-1 strategy

#### Organizational Measures
- **Staff Training:** Annual GDPR training mandatory
- **Access Procedures:** Documented authorization processes
- **Incident Response:** 24/7 monitoring and response plan
- **Vendor Management:** Due diligence and contracts with processors

---

## PROCESSING ACTIVITY 2: USER ACCOUNT MANAGEMENT

### 2.1 Basic Information
- **Activity Name:** EDC System User Account Management
- **Description:** Management of user accounts for researchers and staff accessing the EDC system
- **Controller:** [Your Organization]
- **Data Protection Officer:** [DPO Contact]

### 2.2 Legal Basis
- **Primary:** Article 6(1)(b) - Contract performance (employment/service)
- **Secondary:** Article 6(1)(f) - Legitimate interests (system security)

### 2.3 Data Categories
- Contact information (name, email, phone)
- Authentication data (hashed passwords, tokens)
- Job role and access permissions
- System usage logs

### 2.4 Data Subjects
- **Primary:** EDC system users (investigators, coordinators, data managers)
- **Estimated Numbers:** [X] users

### 2.5 Recipients
- IT security team
- System administrators
- HR department (for employment verification)

### 2.6 Retention Period
- **Active accounts:** Duration of employment/contract + 1 year
- **Access logs:** 7 years for security audit purposes

### 2.7 Security Measures
- Multi-factor authentication required
- Regular access reviews (quarterly)
- Automated account deactivation for inactive users

---

## PROCESSING ACTIVITY 3: REGULATORY REPORTING

### 3.1 Basic Information
- **Activity Name:** Regulatory Safety and Efficacy Reporting
- **Description:** Preparation and submission of clinical trial reports to regulatory authorities
- **Controller:** [Your Organization]

### 3.2 Legal Basis
- **Primary:** Article 6(1)(c) - Legal obligation (regulatory requirements)
- **Special Category:** Article 9(2)(i) - Public health protection

### 3.3 Data Categories
- Aggregated study results
- Individual safety reports (pseudonymized when possible)
- Statistical analyses

### 3.4 Recipients
- **Regulatory Authorities:** FDA, EMA, [National authorities]
- **Public Health Agencies:** [As required by law]

### 3.5 Retention Period
- **Permanent:** Required by regulatory authorities
- **Review:** Data minimization review every 10 years

---

## RECORD MAINTENANCE

### Documentation Updates
- **Review Frequency:** Quarterly
- **Last Review Date:** [Date]
- **Next Review Date:** [Date]
- **Responsible Person:** [DPO/Privacy Officer]

### Change Log
| Date | Change Description | Authorized By |
|------|-------------------|---------------|
| [Date] | Initial record creation | [Name] |
| [Date] | Added international transfers | [Name] |
| [Date] | Updated retention periods | [Name] |

### Supporting Documentation
- ✅ Data Processing Impact Assessments (DPIA)
- ✅ Legitimate interest balancing tests
- ✅ Consent forms and procedures
- ✅ International transfer agreements
- ✅ Vendor data processing agreements
- ✅ Security policy documentation
- ✅ Retention and deletion procedures

---

## COMPLIANCE VERIFICATION

### Internal Controls
- **Privacy by Design:** Implemented in system architecture
- **Data Minimization:** Regular review of collected data fields
- **Accuracy:** Data validation and quality control procedures
- **Security:** Annual penetration testing and security audits

### External Oversight
- **Ethics Committee:** Annual reporting to IRB/Ethics board
- **Regulatory Inspections:** Ready for FDA/EMA inspections
- **Audits:** Annual third-party privacy audit

### Training and Awareness
- **Staff Training:** GDPR training completion rate: [%]
- **Privacy Notices:** Updated and available to all data subjects
- **Breach Preparedness:** Incident response plan tested annually

---

**Prepared By:** [Name and Title]
**Date:** [Date]
**Next Review:** [Date + 1 year]

*This record satisfies GDPR Article 30 requirements. Maintain confidentially and make available to supervisory authorities upon request.*